IP Verse

Compositions Of Tumor Specific Neoantigens - EP3023788

PATENT ANALYSIS

Patent Details

Grant Date: Feb 12, 2020
Company: DANA-FARBER CANCER INSTITUTE, INC.
Oppositions

More patents of Dana-Farber Cancer Institute, Inc.

Want to monitor this patent?

Feel free to send us a message here and we will get back to you